Search research articles
Contact Us
Filters
Showing results (51-60 of 173) with videos related to
Page
of 18
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 2, 1999
Current clinical trials for the treatment of adult Hodgkin's disease: common strategies and perspectives
J Wolf, H Tesch, R Parsa-Parsi, et al.
Journal of Neuro-Oncology
|
September 21, 2002
Intraventricular and intravenous treatment of a patient with refractory primary CNS lymphoma using rituximab
H Pels, H Schulz, O Manzke, et al.
The Cochrane Database of Systematic Reviews
|
February 7, 2008
High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive non-Hodgkin lymphoma (NHL) in adults
A Greb, J Bohlius, D Schiefer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 28, 2019
Thrombosis as a treatment complication in Hodgkin lymphoma patients: a comprehensive analysis of three prospective randomized German Hodgkin Study Group (GHSG) trials
S Borchmann, H Müller, I Hude, et al.
International Journal of Cancer
|
September 30, 1991
Immunotoxins constructed with anti-CD25 monoclonal antibodies and deglycosylated ricin A-chain have potent anti-tumour effects against human Hodgkin cells in vitro and solid Hodgkin tumours in mice
A Engert, G Martin, P Amlot, et al.
Blood
|
August 15, 2000
Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: a report from the German Hodgkin Lymphoma Study Group
A Josting, U Rueffer, J Franklin, et al.
Journal of Molecular Biology
|
September 1, 2000
Combining phage display and screening of cDNA expression libraries: a new approach for identifying the target antigen of an scFv preselected by phage display
S Barth, U Weidenmüller, M K Tur, et al.
Blood
|
September 25, 1999
Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD20 monoclonal antibody (rituximab, IDEC-C2B8)
U Winkler, M Jensen, O Manzke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 19, 2000
Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: is there a chance for cure?
A Josting, M Reiser, U Rueffer, et al.
Annals of Hematology
|
January 25, 2002
Monoclonal antibody therapy with CAMPATH-1H in patients with relapsed high- and low-grade non-Hodgkin's lymphomas: a multicenter phase I/II study
M Uppenkamp, A Engert, V Diehl, et al.
Page
of 18
Search research articles
Search
Showing results (51-60 of 173) with videos related to
Sort By:
Page
of 18
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 2, 1999
Current clinical trials for the treatment of adult Hodgkin's disease: common strategies and perspectives
J Wolf, H Tesch, R Parsa-Parsi, et al.
Journal of Neuro-Oncology
|
September 21, 2002
Intraventricular and intravenous treatment of a patient with refractory primary CNS lymphoma using rituximab
H Pels, H Schulz, O Manzke, et al.
The Cochrane Database of Systematic Reviews
|
February 7, 2008
High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive non-Hodgkin lymphoma (NHL) in adults
A Greb, J Bohlius, D Schiefer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 28, 2019
Thrombosis as a treatment complication in Hodgkin lymphoma patients: a comprehensive analysis of three prospective randomized German Hodgkin Study Group (GHSG) trials
S Borchmann, H Müller, I Hude, et al.
International Journal of Cancer
|
September 30, 1991
Immunotoxins constructed with anti-CD25 monoclonal antibodies and deglycosylated ricin A-chain have potent anti-tumour effects against human Hodgkin cells in vitro and solid Hodgkin tumours in mice
A Engert, G Martin, P Amlot, et al.
Blood
|
August 15, 2000
Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: a report from the German Hodgkin Lymphoma Study Group
A Josting, U Rueffer, J Franklin, et al.
Journal of Molecular Biology
|
September 1, 2000
Combining phage display and screening of cDNA expression libraries: a new approach for identifying the target antigen of an scFv preselected by phage display
S Barth, U Weidenmüller, M K Tur, et al.
Blood
|
September 25, 1999
Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD20 monoclonal antibody (rituximab, IDEC-C2B8)
U Winkler, M Jensen, O Manzke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 19, 2000
Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: is there a chance for cure?
A Josting, M Reiser, U Rueffer, et al.
Annals of Hematology
|
January 25, 2002
Monoclonal antibody therapy with CAMPATH-1H in patients with relapsed high- and low-grade non-Hodgkin's lymphomas: a multicenter phase I/II study
M Uppenkamp, A Engert, V Diehl, et al.
Page
of 18